FDA
approval
· 2019-04-23
FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for donepezil hydrochloride, enabling a generic version of the Alzheimer's disease treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)